HDL Therapeutics, Inc.
9Patents
9Active
9Granted
46Portfolio score
Filing activity: Mar 5, 2008 → May 10, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8048015B2 | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content | Chemistry; Metallurgy | 9 | Active |
| US8030281B2 | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content | Physics | 7 | Active |
| US8268787B2 | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content | Physics | 7 | Active |
| US8637460B2 | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content | Physics | 5 | Active |
| US11027052B2 | Systems and methods for priming fluid circuits of a plasma processing system | Human Necessities | 1 | Active |
| US11033582B1 | Methods for preserving and administering pre-beta high density lipoprotein having a predetermined minimum level of degradation | Physics | 1 | Active |
| US10821133B2 | Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma | Physics | 1 | Active |
| US11400188B2 | Systems for removing air from the fluid circuits of a plasma processing system | Human Necessities | 1 | Active |
| US11903965B2 | Methods for preserving and administering pre-beta high density lipoprotein having a predetermined minimum level of degradation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.